Dcvc Opportunity Fund Ii Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Dcvc Opportunity Fund Ii Gp, LLC
- $113 Million
- Q4 2024
A detailed history of Dcvc Opportunity Fund Ii Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Dcvc Opportunity Fund Ii Gp, LLC holds 3,951,141 shares of RXRX stock, worth $41.6 Million. This represents 23.63% of its overall portfolio holdings.
Number of Shares
3,951,141
Previous 3,951,141
-0.0%
Holding current value
$41.6 Million
Previous $26 Million
2.58%
% of portfolio
23.63%
Previous 26.78%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
331Shares Held
276MCall Options Held
2.53MPut Options Held
2.68M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$154 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...